Revvity (RVTY) Total Non-Current Liabilities (2010 - 2026)
Revvity (RVTY) reported Total Non-Current Liabilities of $4.0 billion for Q2 2026, down 14.69% on a YoY basis from $4.7 billion in Q2 2025, and down 2.37% quarter-over-quarter from $4.1 billion in Q4 2025.
Revvity (RVTY) Total Non-Current Liabilities (2010 - 2026) Analysis & Trends
Revvity has reported Total Non-Current Liabilities for 17 years, with the latest figure at $4.0 billion in Q2 2026.
- For the quarter ending Q2 2026, Total Non-Current Liabilities fell 14.69% year-over-year to $4.0 billion; the trailing twelve-month figure through Apr 2026 stood at $4.0 billion (down 14.69% YoY), and the FY2025 full-year result was $4.1 billion, down 12.61% from the prior year.
- Total Non-Current Liabilities for Q2 2026 stood at $4.0 billion, down from $4.1 billion in the prior quarter.
- The five-year high for Total Non-Current Liabilities was $7.8 billion in Q1 2022, with the low at $4.0 billion in Q3 2024.
- Historically, Total Non-Current Liabilities has averaged $5.5 billion across 5 years, with a median of $5.5 billion in 2022.
- Annual changes were most pronounced in 2022 — Total Non-Current Liabilities soared 84.78% — and 2024, when it fell 16.77%.
- Revvity's Total Non-Current Liabilities stood at $5.5 billion in 2022, then grew by 2.26% to $5.7 billion in 2023, then declined by 16.77% to $4.7 billion in 2024, then slipped by 12.61% to $4.1 billion in 2025, then retreated by 2.37% to $4.0 billion in 2026.
- The last three Total Non-Current Liabilities figures came in at $4.0 billion (Q2 2026), $4.1 billion (Q4 2025), and $4.0 billion (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Non-Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Waters | 29,902.70 Bn | 29,902.24 Bn | 1.11 Bn | 6.97 Bn |
| 2 | Thermo Fisher Scientific | 175.99 Bn | 172.74 Bn | 7.74 Bn | 56.93 Bn |
| 3 | Danaher | 129.87 Bn | 124.18 Bn | 3.59 Bn | 25.03 Bn |
| 4 | Idexx Laboratories | 44.75 Bn | 44.55 Bn | 722.74 Mn | 529.54 Mn |
| 5 | Agilent Technologies | 37.52 Bn | 35.72 Bn | 990.00 Mn | 5.45 Bn |
| 6 | Iqvia Holdings | 30.91 Bn | 28.94 Bn | 1.36 Bn | 22.71 Bn |
| 7 | Natera | 30.21 Bn | 29.11 Bn | 696.04 Mn | 737.18 Mn |
| 8 | Illumina | 24.19 Bn | 23.04 Bn | 721.00 Mn | 3.53 Bn |
| 9 | Mettler Toledo International | 23.12 Bn | 23.06 Bn | 555.82 Mn | 3.42 Bn |
| 10 | Revvity | 11.23 Bn | 10.37 Bn | 387.66 Mn | 4.01 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 5, 2026 | 4.01 Bn |
| Dec 28, 2025 | 4.11 Bn |
| Sep 28, 2025 | 4.01 Bn |
| Jun 29, 2025 | 4.79 Bn |
| Mar 30, 2025 | 4.70 Bn |
| Dec 29, 2024 | 4.70 Bn |
| Sep 29, 2024 | 4.00 Bn |
| Jun 30, 2024 | 5.52 Bn |
| Mar 31, 2024 | 5.56 Bn |
| Dec 31, 2023 | 5.65 Bn |
| Oct 1, 2023 | 4.73 Bn |
| Jul 2, 2023 | 6.31 Bn |
| Apr 2, 2023 | 6.56 Bn |
| Jan 1, 2023 | 6.70 Bn |
| Oct 2, 2022 | 5.53 Bn |
| Jul 3, 2022 | 6.97 Bn |
| Apr 3, 2022 | 7.61 Bn |
| Jan 2, 2022 | 7.80 Bn |
| Oct 3, 2021 | 6.43 Bn |
| Jul 4, 2021 | 4.50 Bn |